|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 9/14 | |||
| A61P 37/06 | |||
| C07K 14/74 | |||
| C12N 5/0781 | |||
| C12N 5/0783 |
| (11) | Number of the document | 3065771 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14858299.2 |
| Date of filing the European patent application | 2014-11-03 | |
| (97) | Date of publication of the European application | 2016-09-14 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2014/003014 |
| Date | 2014-11-03 |
| (87) | Number | WO 2015/063616 |
| Date | 2015-05-07 |
| (30) | Number | Date | Country code |
| 201361899826 P | 2013-11-04 | US |
| (72) |
SANTAMARIA, Pedro, CA
|
| (73) |
UTI Limited Partnership,
3655 36 Street NW, Calgary, AB T2L 1Y8,
CA
|
| (54) | METHODS AND COMPOSITIONS FOR SUSTAINED IMMUNOTHERAPY |
| METHODS AND COMPOSITIONS FOR SUSTAINED IMMUNOTHERAPY |